caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1528125135

Bradley EkstrandM.D., PH.D.

PRACTICECALIFORNIA CANCER CARE A MEDICAL GROUP INCSee all providers at this practice →
Medical OncologySan Mateo, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Bradley Ekstrand's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 20 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Kent Adler
Medical Oncology · San Mateo, CA
83698
Karen Chee
Medical Oncology · San Mateo, CA
61552
Clay Napper
Diagnostic Radiology · San Mateo, CA
50175
Avanti Ambekar
Diagnostic Radiology · San Mateo, CA
46137
Gregory Lim
Diagnostic Radiology · Burlingame, CA
37227
Al Taira
Radiation Oncology · San Mateo, CA
27468
Jeffrey Guttas
Cardiology · San Mateo, CA
2761
Jon Keller
Pathology · Palo Alto, CA
26239
DUNCAN, KEITH2390
Harriet Borofsky
Diagnostic Radiology · San Mateo, CA
2349
Aziz Ahmad
General Surgery · Duarte, CA
17109
Charles Everett
Pulmonary Disease · Burlingame, CA
1686
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
1,188
Beneficiaries
—
Total drug cost
$4.1M
Distinct drugs
29
Brand share
25.4%
Top prescribed drugs
Prednisone292 claims
Abiraterone Acetate255 claims
Ondansetron Hcl60 claims
Apalutamide46 claims
Lorazepam44 claims
QUALITY · MIPS · 2024
Final MIPS score
87.0
Quality
86.8
Cost
70.5
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.51%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,682
Unique beneficiaries
—
Total services
40,748
Distinct HCPCS
35
Medicare payment
$1.7M
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 268 Medical Oncology providers in CA — top quintile (cohort median 1,130).